Downloads provided by UsageCounts
Few studies have been conducted on multimorbidity (two or more chronic diseases) and rational geriatric prescribing in Africa. This study examined the prevalence and determinants of multimorbidity, polypharmacy (five or more long-term medications), and potentially inappropriate medication (PIM) use according to the 2019 Beers criteria among the older adults attending chronic care clinics from a single institution in Ethiopia. A hospital-based cross-sectional study was conducted among 320 randomly selected older adults from 12 March 2020 to 30 August 2020. A multivariable logistic regression analysis was performed to identify the predictor variables. The prevalence of multimorbidity, polypharmacy, and PIM exposure was 59.1%, 24.1%, and 47.2%, respectively. Diuretics (10%), insulin sliding scale (8.8%), amitriptyline (7.8%), and aspirin (6.9%) were among the most frequently prescribed PIMs. Older patients experiencing pain flare-ups were more likely to have multimorbidity (adjusted odds ratio (AOR): 1.64, 95% confidence intervals: 1.13–2.39). Persistent anger (AOR: 3.33; 1.71–6.47) and use of mobility aids (AOR: 2.41, 1.35–4.28) were associated with polypharmacy. Moreover, cognitive impairment (AOR: 1.65, 1.15–2.34) and health deterioration (AOR: 1.61, 1.11–2.32) increased the likelihood of PIM exposure. High prevalence of multimorbidity and PIM use was observed in Ethiopia. Several important determinants that can be modified by applying PIM criteria in routine practice were also identified.
330, multimorbidity, Supplementary Data, prevalence, Pharmaceutical Science, 610, 764632, R Medicine, Article, 2019 Beers criteria, Pharmacy and materia medica, SDG 3 - Good Health and Well-being, Drug Discovery, Prevalence, Chronic, polypharmacy, European Commission, Determinants, older adults, R, Multimorbidity, Outpatient, I-CARE4OLD H2020 -965341, determinants, potentially inappropriate medication use, chronic, RS1-441, Potentially inappropriate medication use, Older adults, outpatient, Polypharmacy, Molecular Medicine, Medicine, Ethiopia
330, multimorbidity, Supplementary Data, prevalence, Pharmaceutical Science, 610, 764632, R Medicine, Article, 2019 Beers criteria, Pharmacy and materia medica, SDG 3 - Good Health and Well-being, Drug Discovery, Prevalence, Chronic, polypharmacy, European Commission, Determinants, older adults, R, Multimorbidity, Outpatient, I-CARE4OLD H2020 -965341, determinants, potentially inappropriate medication use, chronic, RS1-441, Potentially inappropriate medication use, Older adults, outpatient, Polypharmacy, Molecular Medicine, Medicine, Ethiopia
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 22 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
| views | 4 | |
| downloads | 1 |

Views provided by UsageCounts
Downloads provided by UsageCounts